A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression
Table 3
Adjusted 6-month change in myopia progression stratified by baseline characteristics.
Baseline characteristics
0.01% A
0.01% A + AAS
Changes in spherical equivalent (D)a
Age (years)
7∼9
−0.47 ± 0.05 (31)
−0.29 ± 0.05 (35)
0.01
0.30
10∼12
−0.23 ± 0.05 (19)
−0.17 ± 0.07 (15)
0.8
Gender
Male
−0.42 ± 0.07 (22)
−0.27 ± 0.05 (28)
0.08
0.70
Female
−0.33 ± 0.05 (28)
−0.23 ± 0.07 (22)
0.22
Spherical equivalent (D)
≥−2.25
−0.38 ± 0.05 (27)
−0.31 ± 0.05 (32)
0.64
0.07
<−2.25
−0.38 ± 0.06 (23)
−0.13 ± 0.07 (18)
<0.001
Changes in axial length (mm)a
Age (years)
7∼9
0.27 ± 0.03 (31)
0.22 ± 0.02 (35)
0.14
0.61
10∼12
0.19 ± 0.02 (19)
0.17 ± 0.04 (15)
0.57
Gender
Male
0.26 ± 0.03 (22)
0.21 ± 0.03 (28)
0.07
0.13
Female
0.21 ± 0.02 (28)
0.19 ± 0.03 (22)
0.63
Spherical equivalent (D)
≥−2.25
0.23 ± 0.02 (27)
0.23 ± 0.02 (32)
0.57
0.09
<−2.25
0.24 ± 0.03 (23)
0.16 ± 0.03 (18)
0.03
Values are expressed as means ± standard error. aAdjusted for age, sex, baseline spherical equivalent, number of myopic parents, and outdoor time unless stratified by that factor. b value tests for group difference. c value tests for the interaction between treatment and baseline characteristics. Significant at 0.05.
